The m6A methyltransferase METTL3 has been proven to promote PAAD progression, while the demethylase ALKBH5 inhibits PAAD tumorigenesis via posttranscriptional activation of PER1 and regulation of the Wnt pathway (13). Here, MBD2 is linked to pancreatic adenocarcinoma.